6
Orphan Designations
0
FDA Approvals
10
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Alport syndrome | bardoxolone methyl | Orphan Designation | - |
| Hodgkins lymphoma | omaveloxolone | Orphan Designation | - |
| autosomal dominant polycystic kidney disease | bardoxolone methyl | Orphan Designation | - |
| brain glioma | 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI) | Orphan Designation | - |
| malignant glioma | 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI) | Orphan Designation | - |
| malignant pancreatic neoplasm | Bardoxolone | Orphan Designation | - |
| mixed glioma | 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI) | Orphan Designation | - |
| pulmonary arterial hypertension | bardoxolone | Orphan Designation | - |
| stage II endometrioid carcinoma | omaveloxolone | Orphan Designation | - |
| stage IVb bladder cancer | omaveloxolone | Orphan Designation | - |